Column Group Opportunity III GP, LP Insider Trading -- Recent SEC Form 4 Transactions

Column Group Opportunity III GP, LP (CIK 1932874) reported 44 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell TNYA (309,228 shares), Sell TNYA (349,212 shares), Sell TNYA (1.6M shares), Sell TNYA (1.9M shares), Sell TNYA (245,965 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-02-26Tenaya Therapeutics, Inc. (TNYA)InsiderSell309,228$191,721
2026-02-26Tenaya Therapeutics, Inc. (TNYA)InsiderSell349,212$216,511
2026-02-26Tenaya Therapeutics, Inc. (TNYA)InsiderSell1.6M$923,597
2026-02-26Tenaya Therapeutics, Inc. (TNYA)InsiderSell1.9M$1.0M
2026-02-24Tenaya Therapeutics, Inc. (TNYA)InsiderSell245,965$150,039
2026-02-24Tenaya Therapeutics, Inc. (TNYA)InsiderSell277,769$169,439
2026-02-24Tenaya Therapeutics, Inc. (TNYA)InsiderSell143,709$86,225
2026-02-24Tenaya Therapeutics, Inc. (TNYA)InsiderSell162,291$97,375
2026-02-12Tenaya Therapeutics, Inc. (TNYA)InsiderSell161,422$132,366
2026-02-12Tenaya Therapeutics, Inc. (TNYA)InsiderSell182,295$149,482
2026-02-12Tenaya Therapeutics, Inc. (TNYA)InsiderSell1.9M$1.3M
2026-02-12Tenaya Therapeutics, Inc. (TNYA)InsiderSell2.2M$1.5M
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy1.3M$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy1.4M$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy110,928$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy44,249$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy47,898$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy3,785$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy688,283$0
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy1.4M$25.9M
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy49,556$892,008
2026-02-09Eikon Therapeutics, Inc. (EIKN)InsiderBuy630,881$11.4M
2026-01-20Surrozen, Inc./DE (SRZN)InsiderBuy5,590$111,185
2026-01-20Surrozen, Inc./DE (SRZN)InsiderBuy6,303$125,367
2026-01-20Surrozen, Inc./DE (SRZN)InsiderBuy1,204$24,080

Source: SEC Form 4 filings · as of 2026-02-26